Delegations of Authority and Organization; Office of the Commissioner

The Food and Drug Administration (FDA) is amending the delegations of authority regulation that covers general redelegations of authority from the Commissioner of Food and Drugs to other officers of FDA. The amendment delegates an authority related to the waiver and reduction of prescription drug user fees to the Deputy Commissioner for Management and Systems and the Director, Office of Financial Management. Redelegation of this authority would allow for more efficient operations. Additionally, this amendment revokes part of the above authority from the FDA User Fee Waiver Officer, Deputy Chief Mediator and Ombudsman, and the Deputy User Fee Waiver Officer.